Understanding how drugs interact with their molecular targets at the atomic level is central to modern drug discovery.

In recent years, significant therapeutic advances across multiple disease areas—including immuno-oncology, metabolic diseases such as type 2 diabetes and ...

These criteria ensure that the drug offers a genuine therapeutic difference, a requirement for its effectiveness against evolving AMR. Considering it can take 15 years and cost over $1 billion to ...

Recombinant protein expression is a cornerstone of modern biotechnology, fueling advances in drug development, molecular ...

In vivo chimeric antigen receptor (CAR)-T cell engineering uses targeted delivery systems to generate CAR-T cells directly in patients, bypassing ex vivo manufacturing. This Review examines emerging ...

On 15 September 2025, Regeneron Pharmaceuticals conducted a study is researching an experimental drug called REGN5381 (called ...

Glypican-3 (GPC3) has emerged as a promising immunotherapeutic target for hepatocellular carcinoma (HCC). However, its ...

Scientists are exploring how RNA might have jump-started life four billion years ago and how it's now advancing drug ...

Harmony Biosciences Holdings faces setbacks after a failed trial and sNDA rejection. Click here to find out why HRMY is a ...

Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...

Discover Quince Therapeutics’ breakthrough drug-delivery platform aiming to safely treat rare diseases with encapsulated steroids.